Jamjoom Pharma to disclose Q2 2024 financials on Aug. 6
Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Jamjoom Pharmaceuticals Factory Co. plans to disclose Q2 2024 financial statements before the opening of the trading session on the Saudi Exchange (
Tadawul) on Aug. 6, 2024, according to a statement to
Tadawul.
The company will organize a conference call on the same day at 3:00 pm (KSA Timing) after the session close to discuss the investors’ inquiries as regards Q2 financials.
Jamjoom is expected to report a net income of SAR 106.61 million in Q2 2024, according to the analyst forecasts compiled with Argaam.
Comments Analysis: